19 results
8-K
EX-10.1
1rs wgqry
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
424B4
o2cu0q5hs
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
ny4pbnlypbp4zek
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
4n4agr
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.2
5u4q090
9 Jan 14
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next